PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40120F80398FIPPS PHASE 2 DME WORK — Estars Enterprise, LLC

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended May 13, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs

Awarding office

Estars Enterprise, LLC

Recipient

May 13, 2022

PoP end

$707K

Obligated

$4.5M

Potential

541512

NAICS

D307

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number75F40120F80398

Also listed asGS06F0872Z-75F40120F80398

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentEstars Enterprise, LLC

CAGE5FAB7

UEIYLHCLQCME3M7

NAICS541512

PSCD307

Parent IDIQ / IDVGS06F0872Z

Place of performanceSILVER SPRING MD

Pricing typeLabor Hours

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startAug 5, 2020

PoP end (current)May 13, 2022

Obligated$707K

Current value$4.5M

Potential value$4.5M

FIPPS PHASE 2 DME WORK is a federal award for Fda Office Of Acq Grant Svcs held by Estars Enterprise, LLC. Estimated value $4.5M ($707K obligated). Current period of performance ends May 13, 2022. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

Recompete timing

Public

● Past PoP end (1601 days ago)

Current PoP ended May 13, 2022 (1601 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 75F40120F80398? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40120F80398?

75F40120F80398 (FIPPS PHASE 2 DME WORK) is a Fda Office Of Acq Grant Svcs award with a potential value of $4.5M, currently held by Estars Enterprise, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40120F80398?

Fda Office Of Acq Grant Svcs awarded 75F40120F80398 to Estars Enterprise, LLC (potential $4.5M).

Who is the incumbent on 75F40120F80398?

Estars Enterprise, LLC is the incumbent. The current period of performance ends May 13, 2022.

When does Estars Enterprise, LLC’s 75F40120F80398 come up for recompete?

SCOUT tracks a period-of-performance end of May 13, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40120F80398? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Mar 15, 2023 · refreshed monthly